A mother gets her life back after traveling from Virginia to Mercy for surgery to treat severe endometriosis and an ovarian mass.

After suffering from the constant urge to use the restroom along with constant pain, Lynne got relief with the help of Dr. Mark Ellerkmann.

MaryLou was diagnosed with a non-aggressive form of breast cancer and hopes to return to the beach with her family after treatment with Dr. David Riseberg.

Learn more about a long-term health struggle and the trusting relationship one patient established with her doctor at The Institute for Digestive Health and Liver Disease.

Peggy has been a patient of Dr. Gregory Gasbarro's for some time, seeking treatment for the arthritis in her shoulder. After trying non-operative methods, it was time for surgery.

Topic of Study: Breast Cancer This global Phase 3, randomized, double blind study will evaluate the efficacy, safety, and pharmacokinetics of adjuvant Atezolizumab when given in combination with trastuzumab emtansine compared with placebo and trastuzumab emtansine for patients with residual invasive HER2-positive breast cancer following neoadjuvant taxane-based and HER2-targeted therapy including trastuzumab, who are at high risk of disease recurrence. (Clinicaltrials.gov ID#: NCT04873362)

Topic of Study: Gastrointestinal Disease  This study is a phase 4 trial evaluating the effect of obeticholic acid on clinical outcomes in patients with primary biliary cholangitis. (302)

Topic of Study: Gynecologic Cancer

The purpose of this phase II trial is to determine the toxicity and post-operative complications related to cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) as an initial treatment option for patients with ovarian, fallopian tube, or primary peritoneal cancers and its impact on quality of life. Subjects will be randomized to one of two treatment groups: CRS with HIPEC followed by combination chemotherapy, carboplatin and paclitaxel, or CRS only followed by combination chemotherapy carboplatin and paclitaxel.